http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004315381-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9019c0ce5cb7b82c85e121f6cac86dce |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
filingDate | 2003-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e7a54a6c00a15f7ca993a5dd9b559dc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e84306eccf69eb7b168190da4d38aa7 |
publicationDate | 2004-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2004315381-A |
titleOfInvention | Immune disease therapeutic drug and therapeutic kit using stimulation of natural killer T cells by interleukin 18, and method for controlling IgE production |
abstract | The relationship between NKT cells and IL-18 in a cytokine network is elucidated, and a novel therapeutic agent for immunological disease and immunopharmaceutical treatment kit and a method for controlling IgE production are provided using the relationship. SOLUTION: Natural killer T cells (NKT cells) stimulated with interleukin 18 (IL-18) are used as therapeutic agents for immune diseases. For stimulation of NKT cells, interleukin 2 (IL-2) may be used in combination with IL-18. Alternatively, a drug that inhibits stimulation of NKT cells by IL-18 in vivo may be used. Thus, IgE production involving NKT cells can be positively or negatively controlled, and can be used for treatment of various immune diseases. [Selection figure] None |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017093445-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022172944-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111686242-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111686242-B |
priorityDate | 2003-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 167.